Prayer in Commbate to Corona Virus - Covid -19

Sponsor
Hospital do Coracao (Other)
Overall Status
Completed
CT.gov ID
NCT04631380
Collaborator
(none)
200
1
2
17
11.8

Study Details

Study Description

Brief Summary

PATIENTS WHO ARE ADMITTED TO HOSPITALIZATION IN HCOR AND WHO HAVE THE CONFIRMED DIAGNOSIS OF CORONA VIRUS, WILL BE ASKED TO CONSENT TO PARTICIPATE IN THIS STUDY THAT INTENDS TO STUDY THE EFFECTIVENESS OF THE REMOTE INTERCESSION PRAYER IN COMBATING THIS DISEASE.

Condition or Disease Intervention/Treatment Phase
  • Other: PRAYER
N/A

Detailed Description

PATIENTS WHO AGREE TO PARTICIPATE IN THE STUDY WILL BE SEPARATED INTO 2 GROUPS, THE INTERVENTION GROUP AND THE CONTROL GROUP.

THE IDENTITY OF THE PATIENTS WILL BE KEPT IN SECRET AND ONLY THEIR INITIALS WILL BE LISTED.

THE INTERVENTION GROUP WILL RECEIVE DAILY PRAYERS AND THE EVOLUTIONARY CLINICAL RESULTS OF THE TWO GROUPS WILL BE PURCHASED.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
PROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDYPROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDY
Masking:
Single (Participant)
Masking Description:
RAMDOMIZED DOBLE-BLINDING
Primary Purpose:
Other
Official Title:
A Double Blind, Controlled, Randomized, Prospective Study That Will Evaluate the Impact of Remote Intercession Prayer on the Clinical Evolution of Patients Diagnosed With COVID -19 in HCOR.
Actual Study Start Date :
Aug 1, 2020
Actual Primary Completion Date :
Jun 1, 2021
Actual Study Completion Date :
Jan 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: CONTROL

THIS GROUP WILL RECEIVE THE PROTCOLL TREATMENT GIVEN TO PATIENTS COVID -POSITIVE TESTED.

Experimental: PRAYER

THIS GROUP WILL RECEIVE THE SAME TREATMENT GIVEN TO THE CONTROL GROUP, PLUS PRAYERS BY THEOLOGIANS WHOSE PRAYERS INTERCEDE IN FAVOR OF THEIR PROMPT RECOVERY

Other: PRAYER
THE PRAYER GROUP WILL RECEIVE ABSOLUTELY THE SAME CARE AS THE CONTROL GROUP PLUS PRAYERS
Other Names:
  • INTERCESSORY PRAYER
  • Outcome Measures

    Primary Outcome Measures

    1. DEATH OR RECOVERY [60 DAYS]

      WE WILL EVALUATE DEATHS OR HOSPITAL DISCHARGE

    Secondary Outcome Measures

    1. NEED FOR MECHANICAL VENTILATION [60 DAYS]

      NEED FOR MECHANICAL VENTILATION

    2. TIME OF REMAINED INTUBATED [60 DAYS]

      TIME OF REMAINED INTUBATED

    3. LENGTH OF STAY IN ICU [60 DAYS]

      LENGTH OF STAY IN ICU

    4. TIME OF STAY HOSPITALIZED [60 DAYS]

      TIME OF STAY HOSPITALIZED

    5. Occurrence of clinical complications. [60 DAYS]

      Occurrence of clinical complications that were not included before diagnostic confirmation and that may be related to covid infection.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Patients hospitalized in comun hospital rooms and intensive care units with confirmed COVID-19.

    Exclusion Criteria:
    • Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization

    • Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization.

    • Patients 18 years of age or older

    • Patients with indication of palliative care and definition of terminality at hospital admission

    • Patients who voluntarily choose not to participate in the study at the time of the • presentation of the Informed Consent Form.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital do Coracao Sao Paulo SP Brazil 04005-000

    Sponsors and Collaborators

    • Hospital do Coracao

    Investigators

    • Principal Investigator: NATHAN V SOUBIHE JR, Hospital do Coracao

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Hospital do Coracao
    ClinicalTrials.gov Identifier:
    NCT04631380
    Other Study ID Numbers:
    • PRAYER-COVID19
    First Posted:
    Nov 17, 2020
    Last Update Posted:
    Mar 17, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Mar 17, 2022